Scholarly Index
David M. Burger
Radboud University Nijmegen; 18,711 total citations; 595 total publications; best world rank #107
Radboud University Nijmegen
18,711Total citations
595Total publications
65H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| HIV/AIDS drug development and treatment | Lifetime | 158 | NL 5 | 99.29 |
| Pneumocystis jirovecii pneumonia detection and treatment | Lifetime | 164 | NL 1 | 98.89 |
| HIV Research and Treatment | Lifetime | 328 | NL 7 | 99.07 |
| HIV/AIDS Research and Interventions | Lifetime | 391 | NL 5 | 98.99 |
| Pharmacological Effects and Toxicity Studies | Lifetime | 282 | NL 12 | 98.43 |
| Hepatitis C virus research | Lifetime | 643 | NL 11 | 98.29 |
| HIV-related health complications and treatments | Lifetime | 242 | NL 3 | 97.90 |
| Biochemical and Molecular Research | Lifetime | 923 | NL 18 | 95.28 |
| Pharmaceutical studies and practices | Lifetime | 999 | NL 58 | 94.26 |
| Pregnancy and Medication Impact | Lifetime | 729 | NL 32 | 93.45 |
| HIV/AIDS drug development and treatment | 2021-2025 | 107 | NL 3 | 96.04 |
| Pneumocystis jirovecii pneumonia detection and treatment | 2021-2025 | 329 | NL 5 | 88.29 |
| Pharmacological Effects and Toxicity Studies | 2021-2025 | 384 | NL 14 | 88.17 |
| HIV-related health complications and treatments | 2021-2025 | 502 | NL 9 | 84.96 |
| Pharmaceutical studies and practices | 2021-2025 | 932 | NL 65 | 73.71 |